Pharmaceutical industry's big shake-up on the eve? The father of Google's DeepMind claims: AI new drug development will "overturn" "years" in "months".

According to the Securities Times app, new drug research and development often takes several years, and the failure rate is extremely high. However, artificial intelligence (AI) is expected to change this situation. Demis Hassabis, the co-founder and CEO of Google-owned AI lab DeepMind and Nobel Prize winner in chemistry, said that AI will soon shorten the time for new drug research and development from years to months. In an interview, Demis Hassabis said: "In the next few years, I hope to shorten this time to months, not years." "I think this is possible, and may even be faster."